State Street’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
SWM
State Street's SMTI Position: Q2 2026 in Review
State Street increased its Sanara MedTech (SMTI) stake by 1.2% in Q2 2026, buying an estimated $16.1K and bringing the position to 63,469 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3411.
State Street first reported a position in SMTI in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.19M in Q4 2023. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.
- State Street held 63,469 shares of Sanara MedTech worth $1.5M as of Q2 2026.
- State Street bought 780 Sanara MedTech shares in Q2 2026, an estimated $16.1K.
- Sanara MedTech made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3411 holding.
- State Street first reported a position in Sanara MedTech in Q2 2021 and has held it in 20 quarters since.
- State Street's Sanara MedTech position peaked at $2.19M in Q4 2023.
- 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.